Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 9.49 | 14.73 | 14.90 | 12.13 |
Depreciation/ Depletion | 7.09 | 6.37 | 5.77 | 2.52 |
Non- Cash Items | 7.25 | 4.51 | 4.46 | 5.17 |
Changesin Working Capital | -24.21 | -31.90 | -21.02 | -7.05 |
Cashfrom Operating Activities | -0.37 | -6.29 | 4.11 | 12.77 |
Capital Expenditures | -6.29 | -6.60 | -8.61 | -17.97 |
Other Investing Cash Flow Items Total | 0.72 | 0.72 | 0.14 | 0.15 |
Cashfrom Investing Activities | -5.56 | -5.88 | -8.47 | -17.81 |
Financing Cash Flow Items | -7.33 | -2.85 | -1.50 | -0.91 |
Total Cash Dividends Paid | -1.27 | -1.27 | -1.22 | -0.61 |
Issuance( Retirement)of Stock Net | 1.90 | 33.41 | - | 0.00 |
Issuance( Retirement)of Debt Net | 6.63 | -0.17 | 7.02 | 7.36 |
Cashfrom Financing Activities | -0.06 | 29.13 | 4.30 | 5.84 |
Net Changein Cash | -5.99 | 16.95 | -0.07 | 0.80 |
Cash Interest Paid | 4.40 | 2.92 | 1.40 | 1.06 |
Cash Taxes Paid | 3.07 | 3.12 | 3.20 | 4.46 |
Medicamen Biotech Dividend Medicamen Biotech Bonus Medicamen Biotech News Medicamen Biotech AGM Medicamen Biotech Rights Medicamen Biotech Splits Medicamen Biotech Board Meetings Medicamen Biotech Key Metrics Medicamen Biotech Shareholdings Medicamen Biotech Profit Loss Medicamen Biotech Balance Sheet Medicamen Biotech Q1 Results Medicamen Biotech Q2 Results Medicamen Biotech Q3 Results Medicamen Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks